Search - tctmd.com

Displaying 21 - 40 of 1571

Sort: Relevancy | Date

Presentation THT 2026

Artificial Intelligence Meets Real-World Heart Failure: Early Results from the HF-TRACK Trial

Presenter: Shamus Husheer

March 03, 2026

Presentation THT 2026

Incidence of HF Therapy Escalation and Time-to-Clinical Worsening in Atrial Shunt- vs. Sham-Treated Patients with HFpEF/HFmrEF During 5-Year Follow-Up: REDUCE LAP-HF II Trial

Presenter: Grant Reed

March 03, 2026

Presentation THT 2026

Optimal Mean Arterial Pressure, Time in Target Range, and Outcomes in HeartMate 3 Recipients: Pooled Individual-Patient Data from MOMENTUM-3 and ARIES-HM3 Trials

Presenter: Nelson Wang

March 03, 2026

Presentation THT 2026

Left Atrial To Coronary Sinus Shunting In Heart Failure With Mildly Reduced Or Preserved Ejection Fraction: The ALT FLOW Trial (Early Feasibility Study) 3-Year Results

Presenter: Benjamin Hibbert

March 03, 2026

Presentation THT 2026

Microaxial Flow Pump Use in Different Phenotypes of Cardiogenic Shock – a Secondary Analysis of the DanGer Shock Trial

Presenter: Elric Zweck

March 03, 2026

Presentation THT 2026

AI in the Trenches: Lessons From Clinical Trial Optimization

Presenter: Jonathan Cunningham

March 02, 2026

Presentation THT 2026

Autologous Cell Therapy May Curb Pathological Ventricular Remodeling in Chronic Ischemic HFrEF Patients Selected for Favorable Cell Characteristics - Late Breaking Echocardiography Results from the CardiAMP HF trial

Presenter: Amish Raval

March 02, 2026

Presentation CTO 2026

What Do the Trials Say?

Presenter: Ajay J. Kirtane

February 14, 2026

Presentation CTO 2026

What Do the Trials Say (PROCTOR, STAR, INVEST)?

Presenter: James C. Spratt

February 14, 2026

Presentation CTO 2026

What Do the Trials Say (PROTECT, NOBLE 10yrs, etc)?

Presenter: Jeffrey W. Moses

February 13, 2026

Presentation CTO 2026

What Do the Trials Say (ECLIPSE, SHORT-CUT, etc)?

Presenter: Binita Shah

February 13, 2026

Presentation TCT 2025

The Effectiveness and Safety of a Planned Investment Procedure in High-Risk Chronic Total Occlusions - The INVEST CTO Single Arm Study

Presenter: Anja Oksnes

October 28, 2025

Presentation TCT 2025

AI-Enabled ECG Interpretation in STEMI: Findings from a Multicenter U.S. Registry

Presenter: Timothy D. Henry

October 28, 2025

Presentation TCT 2025

A Prospective, Randomized Clinical Trial of Hemodynamic Support with a Newly Developed pVAD Versus IABP in Patients Undergoing High-Risk Percutaneous Coronary Intervention

Presenter: Rui Wang

October 28, 2025

Presentation TCT 2025

Randomized Comparison of the Supraflex CruzTM vs. SYNERGYTM Drug-Eluting Stents: The Multivessel TALENT Randomized Trial

Presenter: Patrick W. Serruys

October 28, 2025

Presentation TCT 2025

iFR Versus Angiography-Guided CABG: 3-Year Results of the iCABG Randomized Trial

Presenter: Rasa Ordiene

October 28, 2025

Presentation TCT 2025

Commentary

Presenter: Tullio Palmerini

October 28, 2025

Presentation TCT 2025

Supraflex Cruz versus Xience in Patients with Diabetes and Multivessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: Results from the TUXEDO-2 Randomized Trial

Presenter: Upendra Kaul

October 28, 2025

Presentation TCT 2025

Commentary

Presenter: Shrilla Banerjee

October 28, 2025

Presentation TCT 2025

Stratified Treatment of Myocardial Infarction with Non-Obstructive Coronary Arteries: The PROMISE Trial

Presenter: Rocco Antonio Montone

October 28, 2025

Advertisement

Artificial Intelligence Meets Real-World Heart Failure: Early Results from the HF-TRACK Trial

Incidence of HF Therapy Escalation and Time-to-Clinical Worsening in Atrial Shunt- vs. Sham-Treated Patients with HFpEF/HFmrEF During 5-Year Follow-Up: REDUCE LAP-HF II Trial

Optimal Mean Arterial Pressure, Time in Target Range, and Outcomes in HeartMate 3 Recipients: Pooled Individual-Patient Data from MOMENTUM-3 and ARIES-HM3 Trials

Left Atrial To Coronary Sinus Shunting In Heart Failure With Mildly Reduced Or Preserved Ejection Fraction: The ALT FLOW Trial (Early Feasibility Study) 3-Year Results

Microaxial Flow Pump Use in Different Phenotypes of Cardiogenic Shock – a Secondary Analysis of the DanGer Shock Trial

AI in the Trenches: Lessons From Clinical Trial Optimization

Autologous Cell Therapy May Curb Pathological Ventricular Remodeling in Chronic Ischemic HFrEF Patients Selected for Favorable Cell Characteristics - Late Breaking Echocardiography Results from the CardiAMP HF trial

What Do the Trials Say?

What Do the Trials Say (PROCTOR, STAR, INVEST)?

What Do the Trials Say (PROTECT, NOBLE 10yrs, etc)?

What Do the Trials Say (ECLIPSE, SHORT-CUT, etc)?

The Effectiveness and Safety of a Planned Investment Procedure in High-Risk Chronic Total Occlusions - The INVEST CTO Single Arm Study

AI-Enabled ECG Interpretation in STEMI: Findings from a Multicenter U.S. Registry

A Prospective, Randomized Clinical Trial of Hemodynamic Support with a Newly Developed pVAD Versus IABP in Patients Undergoing High-Risk Percutaneous Coronary Intervention

Randomized Comparison of the Supraflex CruzTM vs. SYNERGYTM Drug-Eluting Stents: The Multivessel TALENT Randomized Trial

iFR Versus Angiography-Guided CABG: 3-Year Results of the iCABG Randomized Trial

Commentary

Supraflex Cruz versus Xience in Patients with Diabetes and Multivessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: Results from the TUXEDO-2 Randomized Trial

Commentary

Stratified Treatment of Myocardial Infarction with Non-Obstructive Coronary Arteries: The PROMISE Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content